This trial is testing whether neurofeedback from the supplementary motor area can help reduce tics in adolescents with Tourette Syndrome.
- Tourette Syndrome
1 Primary · 1 Secondary · Reporting Duration: Baseline and one month post-NF
2 Treatment Groups
Neurofeedback from control region
1 of 2
Neurofeedback from the SMA
1 of 2
64 Total Participants · 2 Treatment Groups
Primary Treatment: Neurofeedback from the SMA · No Placebo Group · N/A
Who is running the clinical trial?
Age 10 - 16 · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
What is the participant count of this clinical experiment?
"Affirmative. Clinicaltrials.gov corroborates that this clinical trial is currently attempting to find 64 participants from 1 medical site. This research was posted on November 1st 2022 with the last update occurring on November 21st 2022." - Anonymous Online Contributor
Is the cutoff age for enrolment in this research endeavour higher than 85 years old?
"The requirements for participation in this experiment indicates that the age of participants must be between 10 and 16 years old. Furthermore, there are 382 clinical trials designed specifically for youngsters under 18, as well as 990 for senior citizens over 65." - Anonymous Online Contributor
Are any volunteers being sought for this trial at this time?
"Indeed, clinicaltrials.gov reveals that this medical trial is still recruiting participants since its inception on November 1st 2022. The investigation has been updated recently and requires 64 patients to be enrolled across one site." - Anonymous Online Contributor
Could I potentially qualify to join this medical experiment?
"This study seeks a total of 64 patients suffering from Gilles de la Tourette Syndrome aged between 10 and 16." - Anonymous Online Contributor